Tonix Pharmaceuticals (TNXP) Misses Q2 EPS by 8c

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q2 EPS of ($0.73), $0.08 worse than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
• Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook